Tag Archives: CHI Healthtech
Multitargeted Therapies: Promiscuous Drugs and Combination Therapies
Report Summary Suites of drugs have been developed that can be used in combination to treat complex diseases that have multiple causes involving multiple targets. In addition, it has been… Read more
Multiplex Assays: Evolving Technologies, Applications and Future Directions
Multiplex Assays: Evolving Technologies, Applications and Future Directions Price: Single User License: US $ 2995 Corporate User License: US $ 9950 Report Description: Multiplex Assays: Evolving Technologies, Applications and Future… Read more
Kinase Therapeutics: Pipeline Assessment and Commercial Prospects
Kinase Therapeutics: Pipeline Assessment and Commercial Prospects Price: Single User License: US $ 2995 Corporate User License: US $ 9950 Report Description The number of kinase inhibitors entering clinical development… Read more
Strategic Alliances: Synergistic Path to Value Creation
Strategic Alliances: Synergistic Path to Value Creation Price: Single User License: US $ 2995 Corporate User License: US $ 9950 As the first decade of the 21st century comes to… Read more